Finance

Lists
Q3 2026 earnings • released • EPS beat +33.11% • Revenue beat +2.02%
See results
SHL:ETR
Siemens Healthineers AG
€38.54
+4.56%
(+1.68) 1D
Aug 3, 9:42:08 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SHL...
Open
€37.96
High
€38.71
Low
€37.96
Mkt. cap
43.32B
Avg. vol.
1.13M
Volume
166.32K
Dividend
2.59%
Quarterly dividend
€0.25
Ex-dividend date
Feb 6, 2026
P/E ratio
20.67
52-wk high
€49.71
52-wk low
€32.81
EPS
€1.86
Shares outstanding
1.13B
No. of employees
74K
Open
€37.96
High
€38.71
Low
€37.96
Mkt. cap
43.32B
Avg. vol.
1.13M
Volume
166.32K
Dividend
2.59%
Quarterly dividend
€0.25
Ex-dividend date
Feb 6, 2026
P/E ratio
20.67
52-wk high
€49.71
52-wk low
€32.81
EPS
€1.86
Shares outstanding
1.13B
No. of employees
74K
News stories
From sources across the web
Profile
Siemens Healthineers is a German multinational company with specializing in medical technology and medical imaging. It was spun off from its parent company Siemens in 2017, which retains a 75% stake. Siemens Healthineers is the parent company for several medical technology companies and is headquartered in Erlangen, Germany. Wikipedia
About Siemens Healthineers AG
CEOBernd Montag
Employees73.8K
FoundedOct 1, 1847
HeadquartersErlangen, Bavaria, Germany
SectorMedical device
Last report
Jul 31, 2026
Fiscal period
Q3 2026
EPS / Est. (EUR)
€0.70 / €0.53
+33.11%beat
Revenue / Est. (EUR)
5.76B / 5.65B
+2.02%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.32B
5.40B
5.68B
5.76B
Cost of goods sold
3.95B
3.33B
3.54B
-
Cost of revenue
3.95B
3.33B
3.54B
-
Research and development expenses
499.00M
476.00M
487.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
975.00M
925.00M
963.00M
-
Operating expense
1.48B
1.40B
1.42B
-
Total operating expenses
5.43B
4.72B
4.96B
-
Operating income
892.00M
678.00M
724.00M
-
Other non operating income
-350.00M
-5.00M
-1.00M
-
EBT including unusual items
770.00M
602.00M
644.00M
-
EBT excluding unusual items
770.00M
602.00M
644.00M
-
Income tax expense
174.00M
147.00M
132.00M
-
Effective tax rate
22.60%
24.42%
20.50%
-
Other operating expenses
8.00M
-3.00M
-34.00M
-
Net income
588.00M
449.00M
506.00M
-
Net profit margin
9.30%
8.31%
8.91%
11.61%
Earnings per share
0.68
0.49
0.53
0.70
Interest and investment income
18.00M
24.00M
22.00M
-
Interest expense
-108.00M
-96.00M
-100.00M
-
Net interest expenses
-90.00M
-72.00M
-78.00M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.20B
976.00M
1.02B
-
Gain or loss from assets sale
36.00M
-1.00M
2.00M
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps